Laura Rigamonti
- Oncology top 10%
- Immunology
- Molecular Biology
- Hematology top 5%
- Physiology
- Co-authors
- Francesco NovelliGuido ForniA CantaGuido CavalettiP MarmiroliVirginia Rodriguez‐MenendezAlessandra GilardiniR. De Coster
- Topics
- Immune Cell Function and Interaction (5 papers)T-cell and B-cell Immunology (4 papers)Pain Mechanisms and Treatments (2 papers)
- Cited by
- HematologyOncologyImmunology
- Partner nations
- ItalyFranceUnited States
In The Last Decade
Laura Rigamonti
13 papers receiving 669 citations
Peers
Comparison fields: 5 of 92
- Oncology 329
- Immunology 203
- Molecular Biology 160
- Hematology 151
- Physiology 129
Countries citing papers authored by Laura Rigamonti
This map shows the geographic impact of Laura Rigamonti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Rigamonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Rigamonti more than expected).
Fields of papers citing papers by Laura Rigamonti
This network shows the impact of papers produced by Laura Rigamonti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Rigamonti. The network helps show where Laura Rigamonti may publish in the future.
Co-authorship network of co-authors of Laura Rigamonti
This figure shows the co-authorship network connecting the top 25 collaborators of Laura Rigamonti. A scholar is included among the top collaborators of Laura Rigamonti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Rigamonti. Laura Rigamonti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 218 | |
| 3 | Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties. | 68 |
| 4 | 54 | |
| 5 | Chemotherapy-induced allodinia: neuroprotective effect of acetyl-L-carnitine. | 34 |
| 6 | 24 | |
| 7 | IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes. | 25 |
| 8 | 20 | |
| 9 | 23 | |
| 10 | 103 | |
| 11 | 44 | |
| 12 | 46 | |
| 13 | 20 |
About Laura Rigamonti
Laura Rigamonti is a scholar working on Immunology, Oncology and Rehabilitation, having authored 13 papers that have together received 689 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and Pain Mechanisms and Treatments (2 papers). The work is most often cited by research in Hematology (151 citations), Oncology (329 citations) and Immunology (203 citations). Laura Rigamonti has collaborated with scholars based in Italy, France and United States. Frequent co-authors include Francesco Novelli, Guido Forni, A Canta, Guido Cavaletti, P Marmiroli, Virginia Rodriguez‐Menendez, Alessandra Gilardini, R. De Coster, Maurizio D’Incalci and M Bossi. Their work appears in journals such as The Journal of Immunology, European Journal of Immunology and Experimental Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.